Shopping Cart 0
Cart Subtotal
AED 0

Pet Healthcare in the United Kingdom

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 1285

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 2569

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 3854
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Pet Healthcare in the United Kingdom

Summary

Pet Healthcare in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the United Kingdom pet healthcare market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights

- The pet healthcare market consists of retail sale of pet supplements, worming treatments, external parasite treatments, grooming products and other pet healthcare. The market is valued according to retail selling price (RSP) and includes any applicable taxes. All currency conversions used in the creation of this report have been calculated using constant annual average 2017 exchange rates.

- The UK pet healthcare market had total revenues of USD 683.9m in 2017, representing a compound annual growth rate (CAGR) of 2.5% between 2013 and 2017.

- Market consumption volume increased with a CAGR of 2.2% between 2013 and 2017, to reach a total of 94.1 million units in 2017.

- Growth in the market can be attributed to the improving economy, coupled with increasing disposable income and a rise in consumer spending, which is empowering UK residents to choose premium pet healthcare products over value for money items.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pet healthcare market in the United Kingdom

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pet healthcare market in the United Kingdom

- Leading company profiles reveal details of key pet healthcare market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the United Kingdom pet healthcare market with five year forecasts by both value and volume

Reasons to buy

- What was the size of the United Kingdom pet healthcare market by value in 2017?

- What will be the size of the United Kingdom pet healthcare market in 2022?

- What factors are affecting the strength of competition in the United Kingdom pet healthcare market?

- How has the market performed over the last five years?

- Who are the top competitiors in the United Kingdom's pet healthcare market?

READ MORE

Table Of Content

Scope

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Market volume 2

Market volume forecast 2

Category segmentation 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 8

Market value 8

Market volume 9

Market Segmentation 10

Category segmentation 10

Geography segmentation 11

Market share 12

Market distribution 13

Market Outlook 14

Market value forecast 14

Market volume forecast 15

Five Forces Analysis 16

Summary 16

Buyer power 17

Supplier power 18

New entrants 19

Threat of substitutes 20

Degree of rivalry 21

Leading Companies 22

Bayer AG 22

Bob Martin (UK) Limited 26

Sanofi SA 27

Macroeconomic Indicators 31

Country data 31

Methodology 33

Industry associations 34

Related MarketLine research 34

Appendix 35

About MarketLine 35


List Of Figure

List of Figures

Figure 1: United Kingdom pet healthcare market value: USD million, 2013-17

Figure 2: United Kingdom pet healthcare market volume: million units, 2013-17

Figure 3: United Kingdom pet healthcare market category segmentation: % share, by value, 2017

Figure 4: United Kingdom pet healthcare market geography segmentation: % share, by value, 2017

Figure 5: United Kingdom pet healthcare market share: % share, by value, 2017

Figure 6: United Kingdom pet healthcare market distribution: % share, by value, 2017

Figure 7: United Kingdom pet healthcare market value forecast: USD million, 2017-22

Figure 8: United Kingdom pet healthcare market volume forecast: million units, 2017-22

Figure 9: Forces driving competition in the pet healthcare market in the United Kingdom, 2017

Figure 10: Drivers of buyer power in the pet healthcare market in the United Kingdom, 2017

Figure 11: Drivers of supplier power in the pet healthcare market in the United Kingdom, 2017

Figure 12: Factors influencing the likelihood of new entrants in the pet healthcare market in the United Kingdom, 2017

Figure 13: Factors influencing the threat of substitutes in the pet healthcare market in the United Kingdom, 2017

Figure 14: Drivers of degree of rivalry in the pet healthcare market in the United Kingdom, 2017

Figure 15: Bayer AG: revenues & profitability

Figure 16: Bayer AG: assets & liabilities

Figure 17: Sanofi SA: revenues & profitability

Figure 18: Sanofi SA: assets & liabilities


List Of Table

List of Tables

Table 1: United Kingdom pet healthcare market value: USD million, 2013-17

Table 2: United Kingdom pet healthcare market volume: million units, 2013-17

Table 3: United Kingdom pet healthcare market category segmentation: USD million, 2017

Table 4: United Kingdom pet healthcare market geography segmentation: USD million, 2017

Table 5: United Kingdom pet healthcare market share: % share, by value, 2017

Table 6: United Kingdom pet healthcare market distribution: % share, by value, 2017

Table 7: United Kingdom pet healthcare market value forecast: USD million, 2017-22

Table 8: United Kingdom pet healthcare market volume forecast: million units, 2017-22

Table 9: Bayer AG: key facts

Table 10: Bayer AG: key financials (USD )

Table 11: Bayer AG: key financials (EUR)

Table 12: Bayer AG: key financial ratios

Table 13: Bob Martin (UK) Limited: key facts

Table 14: Sanofi SA: key facts

Table 15: Sanofi SA: key financials (USD )

Table 16: Sanofi SA: key financials (EUR)

Table 17: Sanofi SA: key financial ratios

Table 18: United Kingdom size of population (million), 2013-17

Table 19: United Kingdom gdp (constant 2005 prices, USD billion), 2013-17

Table 20: United Kingdom gdp (current prices, USD billion), 2013-17

Table 21: United Kingdom inflation, 2013-17

Table 22: United Kingdom consumer price index (absolute), 2013-17

Table 23: United Kingdom exchange rate, 2013-17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Bayer AG

Bob Martin (UK) Limited

Sanofi SA

Pet Healthcare in the United Kingdom

Summary

Pet Healthcare in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the United Kingdom pet healthcare market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights

- The pet healthcare market consists of retail sale of pet supplements, worming treatments, external parasite treatments, grooming products and other pet healthcare. The market is valued according to retail selling price (RSP) and includes any applicable taxes. All currency conversions used in the creation of this report have been calculated using constant annual average 2017 exchange rates.

- The UK pet healthcare market had total revenues of USD 683.9m in 2017, representing a compound annual growth rate (CAGR) of 2.5% between 2013 and 2017.

- Market consumption volume increased with a CAGR of 2.2% between 2013 and 2017, to reach a total of 94.1 million units in 2017.

- Growth in the market can be attributed to the improving economy, coupled with increasing disposable income and a rise in consumer spending, which is empowering UK residents to choose premium pet healthcare products over value for money items.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pet healthcare market in the United Kingdom

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pet healthcare market in the United Kingdom

- Leading company profiles reveal details of key pet healthcare market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the United Kingdom pet healthcare market with five year forecasts by both value and volume

Reasons to buy

- What was the size of the United Kingdom pet healthcare market by value in 2017?

- What will be the size of the United Kingdom pet healthcare market in 2022?

- What factors are affecting the strength of competition in the United Kingdom pet healthcare market?

- How has the market performed over the last five years?

- Who are the top competitiors in the United Kingdom's pet healthcare market?

READ MORE

Scope

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Market volume 2

Market volume forecast 2

Category segmentation 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 8

Market value 8

Market volume 9

Market Segmentation 10

Category segmentation 10

Geography segmentation 11

Market share 12

Market distribution 13

Market Outlook 14

Market value forecast 14

Market volume forecast 15

Five Forces Analysis 16

Summary 16

Buyer power 17

Supplier power 18

New entrants 19

Threat of substitutes 20

Degree of rivalry 21

Leading Companies 22

Bayer AG 22

Bob Martin (UK) Limited 26

Sanofi SA 27

Macroeconomic Indicators 31

Country data 31

Methodology 33

Industry associations 34

Related MarketLine research 34

Appendix 35

About MarketLine 35


List Of Figure

List of Figures

Figure 1: United Kingdom pet healthcare market value: USD million, 2013-17

Figure 2: United Kingdom pet healthcare market volume: million units, 2013-17

Figure 3: United Kingdom pet healthcare market category segmentation: % share, by value, 2017

Figure 4: United Kingdom pet healthcare market geography segmentation: % share, by value, 2017

Figure 5: United Kingdom pet healthcare market share: % share, by value, 2017

Figure 6: United Kingdom pet healthcare market distribution: % share, by value, 2017

Figure 7: United Kingdom pet healthcare market value forecast: USD million, 2017-22

Figure 8: United Kingdom pet healthcare market volume forecast: million units, 2017-22

Figure 9: Forces driving competition in the pet healthcare market in the United Kingdom, 2017

Figure 10: Drivers of buyer power in the pet healthcare market in the United Kingdom, 2017

Figure 11: Drivers of supplier power in the pet healthcare market in the United Kingdom, 2017

Figure 12: Factors influencing the likelihood of new entrants in the pet healthcare market in the United Kingdom, 2017

Figure 13: Factors influencing the threat of substitutes in the pet healthcare market in the United Kingdom, 2017

Figure 14: Drivers of degree of rivalry in the pet healthcare market in the United Kingdom, 2017

Figure 15: Bayer AG: revenues & profitability

Figure 16: Bayer AG: assets & liabilities

Figure 17: Sanofi SA: revenues & profitability

Figure 18: Sanofi SA: assets & liabilities


List Of Table

List of Tables

Table 1: United Kingdom pet healthcare market value: USD million, 2013-17

Table 2: United Kingdom pet healthcare market volume: million units, 2013-17

Table 3: United Kingdom pet healthcare market category segmentation: USD million, 2017

Table 4: United Kingdom pet healthcare market geography segmentation: USD million, 2017

Table 5: United Kingdom pet healthcare market share: % share, by value, 2017

Table 6: United Kingdom pet healthcare market distribution: % share, by value, 2017

Table 7: United Kingdom pet healthcare market value forecast: USD million, 2017-22

Table 8: United Kingdom pet healthcare market volume forecast: million units, 2017-22

Table 9: Bayer AG: key facts

Table 10: Bayer AG: key financials (USD )

Table 11: Bayer AG: key financials (EUR)

Table 12: Bayer AG: key financial ratios

Table 13: Bob Martin (UK) Limited: key facts

Table 14: Sanofi SA: key facts

Table 15: Sanofi SA: key financials (USD )

Table 16: Sanofi SA: key financials (EUR)

Table 17: Sanofi SA: key financial ratios

Table 18: United Kingdom size of population (million), 2013-17

Table 19: United Kingdom gdp (constant 2005 prices, USD billion), 2013-17

Table 20: United Kingdom gdp (current prices, USD billion), 2013-17

Table 21: United Kingdom inflation, 2013-17

Table 22: United Kingdom consumer price index (absolute), 2013-17

Table 23: United Kingdom exchange rate, 2013-17

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Bayer AG

Bob Martin (UK) Limited

Sanofi SA